Medtech Insights

The European interventional oncology device market is projected to see modest growth through 2034, driven by rising cancer incidence and prevalence rates, updated clinical guidelines, and emerging…

The Asia Pacific interventional oncology device market will see strong growth through 2034, driven by updated clinical guidelines, broader access to minimally invasive cancer treatments, and…

The Asia Pacific interventional oncology device market will see strong growth through 2033, driven by large and rapidly expanding patient population, increasing popularity of minimally invasive…

The European interventional oncology device market will see modest growth through 2033, driven by increasing incidence and prevalence rates of cancer, cost-effectiveness of ablation and…

The US market for interventional oncology devices will be driven by uptake of advanced and higher-priced technologies—such as radioembolization—favorable clinical data, expanding populations…

Although the interventional oncology procedure volumes are increasing marginally in Japan, the Japanese interventional oncology device market will decline due to limited adoption of minimally…

The European interventional oncology device market will see modest growth through 2033, driven by increasing incidence and prevalence rates of cancer, cost-effectiveness of ablation and…

The Asia Pacific interventional oncology device market will see strong growth through 2033, driven by large and rapidly expanding patient population, increasing popularity of minimally invasive…

The Asia Pacific interventional oncology device market will see strong growth through 2032 driven by a large and rapidly expanding patient population, increasing popularity of minimally invasive…

The European interventional oncology device market will see moderate growth through 2032, driven by improved reimbursement, increasing popularity of minimally invasive surgeries, and growing…

The US market for interventional oncology devices will grow through 2032. This will be driven largely by the increasing shift toward higher-priced technologies, such as radioembolization, and…

The Japanese interventional oncology device market will grow slowly due to limited adoption of minimally invasive interventional oncology procedures, substantiated by Japanese guidelines and…